
Polypill plus aspirin prevents primary CVD events in people at medium risk (TIPS-3)
This multicentre, 2-by-2-by-2 factorial study randomised 5713 participants with medium cardiovascular disease (CVD) risk to receive a polypill (containing a statin and three blood pressure